3'-Fluoro-deoxythymidine-5-fluorophosphate--an effective inhibitor of reproduction of human immunodeficiency virus in cell cultures
Arzumanov, A.A.; Diatkina, N.B.; Kukhanova, M.K.; Kraevskiĭ, A.A.; Semchenko, F.M.; Eremin, O.G.; Martynov, B.I.
Bioorganicheskaia Khimiia 19(10): 978-980
1993
ISSN/ISBN: 0132-3423 PMID: 8274172 Document Number: 421499
3'-Fluoro-3'-deoxythymidine 5'-phosphorofluoridate was synthesised and shown to effectively inhibit the HIV reproduction in cell cultures, thus opening a new group of potential antiretroviral nucleoside derivatives.
Document emailed within 1 workday
Related Documents
Gerna, G.; Favino, A.; Cereda, P.; Minoia, C. 1975: Nonvirionic inhibitor of DNA synthesis in human embryo fibroblast cell cultures infected with rubella virus Bollettino dell'Istituto Sieroterapico Milanese 54(1): 1-4Rasheed, S.; Li, Z.; Xu, D.; Kovacs, A. 1996: Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women American Journal of Obstetrics and Gynecology 175(1): 122-129
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Izbický, A.; Casný, J. 1981: Reproduction of mumps virus strains in Vero cell cultures at 32, 37 and 40 degrees C Acta Virologica 25(4): 213-218
Mandelbrot, L.; Henrion, R. 1991: Human immunodeficiency virus and reproduction Annals of the new York Academy of Sciences 626: 484-501
Chiba, M.; Hensleigh, M.; Nishime, J.A.; Balani, S.K.; Lin, J.H. 1996: Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor Drug Metabolism and Disposition: the Biological Fate of Chemicals 24(3): 307-314
Lillibridge, J.H.; Liang, B.H.; Kerr, B.M.; Webber, S.; Quart, B.; Shetty, B.V.; Lee, C.A. 1998: Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(7): 609-616
Pampuro, S.E.; Rabinovich, R.D.; Martinez Peralta, L.; Gallo, D.; Hanson, C.; Libonatti, O. 1993: Presence of human T-cell lymphotropic virus types i and Ii and coinfection with human immunodeficiency virus in different groups at risk in Argentina Journal of Acquired Immune Deficiency Syndromes 6(7): 851-852
Pampuro, S.E.; Rabinovich, R.D.; Martinez Peralta, L.; Gallo, D.; Hanson, C.; Libonatti, O. 1993: Presence of human T-cell lymphotropic virus types i and Ii and coinfection with human immunodeficiency virus in different groups at risk in Argentina Journal of Acquired Immune Deficiency Syndromes 6(7): 851-852
Zhang, S.M.; He, Y.S.; Tabba, H.D.; Smith, K.M. 1988: Inhibitor against the human immunodeficiency virus in aqueous extracts of Alternanthera philoxeroides Chinese Medical Journal 101(11): 861-866
Nosik, M.N.; Stepanova, L.G.; Matsevich, G.R. 1995: Quantitative determination of the infective activity of the human immunodeficiency virus by plaque formation using monolayer cultures Voprosy Virusologii 40(5): 202-205
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455
McMahon, J.B.; Buckheit, R.W.; Gulakowski, R.J.; Currens, M.J.; Vistica, D.T.; Shoemaker, R.H.; Stinson, S.F.; Russell, J.D.; Bader, J.P.; Narayanan, V.L.; Schultz, R.J.; Brouwer, W.G.; Felauer, E.E.; Boyd, M.R. 1996: Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor Journal of Pharmacology and Experimental Therapeutics 276(1): 298-305
1988: Guidelines on sterilization and high-level disinfection methods effective against human immunodeficiency virus (HIV) Bulletin of the International Union Against Tuberculosis and Lung Disease 63(2): 7-11
Sabidó, M.; Lahuerta, M.; Montoliu, A.; Gonzalez, V.; Hernández, G.; Giardina, F.; Monzón, J.é E.; Pedroza, M.I.; Casabona, J. 2011: Human immunodeficiency virus, sexually transmitted infections, and risk behaviors among clients of sex workers in Guatemala: are they a bridge in human immunodeficiency virus transmission? Sexually Transmitted Diseases 38(8): 735-742
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866
Wen, Y.; Guan, J.; Wu, Z.; Li, L.; Rotheram-Borus, M.Jane.; Lin, C.; Detels, R. 2009: Pharmacy workers' sexually transmitted diseases/human immunodeficiency virus knowledge in Fuzhou, China: implications for human immunodeficiency virus testing, treatment, and prevention strategies Sexually Transmitted Diseases 36(4): 221-226
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22
Harshbarger, C.L.; O'Donnell, L.N.; Warner, L.; Margolis, A.D.; Richardson, D.B.; Novey, S.R.; Glover, L.C.; Klausner, J.D.; Malotte, C.Kevin.; Rietmeijer, C.A. 2012: Safe in the city: effective prevention interventions for human immunodeficiency virus and sexually transmitted infections American Journal of Preventive Medicine 42(5): 468-472